News about how well the single-dose coronavirus vaccine by Johnson & Johnson works could come in two weeks, said Dr. Anthony Fauci, the top US infectious disease expert.
"I don’t want to get ahead of them, but I have to tell you I would be surprised if it was any more than two weeks from now that data will be analyzed, and decisions would be made,” Fauci told MSNBC's Rachel Maddow Friday .
"The data will be analyzed in the similar fashion, the way we analyzed it with the Moderna and the Pfizer candidate,” added Fauci, who as director of the National Institute of Allergy and Infectious Diseases has helped with some of the clinical trials involving the Moderna and Johnson & Johnson vaccines.
Vaccines made by Pfizer and Moderna secured emergency use authorization (EUA) from the US Food and Drug Administration in December. Johnson & Johnson is widely expected to be the third company to apply for an EUA for a coronavirus vaccine in the US.